Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,812 | -17,284 | -91,426 | -55,146 | -51,514 |
| Depreciation Amortization | 2,976 | 1,929 | 40,819 | 29,689 | 19,190 |
| Accounts receivable | 828 | 2,937 | -3,417 | -518 | 550 |
| Other Working Capital | -2,303 | -11,940 | -19,689 | -31,909 | -30,226 |
| Other Operating Activity | 17,925 | 4,234 | 32,647 | 11,643 | 12,197 |
| Operating Cash Flow | $-5,386 | $-20,124 | $-41,066 | $-46,241 | $-49,803 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -531 | -7 | -397 | -397 | -397 |
| Purchase Of Investment | -239,422 | -142,789 | -349,457 | -278,438 | -87,407 |
| Sale Of Investment | 225,155 | 128,576 | 420,580 | 334,233 | 227,459 |
| Investing Cash Flow | $-14,798 | $-14,220 | $70,726 | $55,398 | $139,655 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 116,734 | 117,551 | N/A |
| Debt Repayment | N/A | N/A | 57 | -38,129 | N/A |
| Common Stock Issued | N/A | N/A | -38,111 | 18 | 18 |
| Common Stock Repurchased | -3,862 | N/A | -75,825 | -75,825 | N/A |
| Other Financing Activity | -380 | -318 | -1,737 | -1,532 | -1,325 |
| Financing Cash Flow | $-4,242 | $-318 | $1,118 | $2,083 | $-1,307 |
| Exchange Rate Effect | -2,977 | -274 | -2,023 | 71 | -522 |
| Beginning Cash Position | 94,409 | 94,409 | 65,654 | 65,654 | 65,654 |
| End Cash Position | 67,006 | 59,473 | 94,409 | 76,965 | 153,677 |
| Net Cash Flow | $-27,403 | $-34,936 | $28,755 | $11,311 | $88,023 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,386 | -20,124 | -41,066 | -46,241 | -49,803 |
| Capital Expenditure | -531 | -7 | -397 | -397 | -397 |
| Free Cash Flow | -5,917 | -20,131 | -41,463 | -46,638 | -50,200 |